Announced details
Lung cancer screening in Kyoto Prefecture; chest X-ray image interpretation support
Pilot use in Uji City lung cancer screening in FY2025. Full-scale deployment in lung cancer screening in Kyoto Prefecture is scheduled for FY2026.
PSP株式会社 is a consolidated subsidiary of TECHMATRIX CORPORATION, with a 50.02% ownership stake. PSP, the Kyoto Prefecture Medical Association and Preferred Networks jointly developed this image interpretation support program. PSP obtained medical device certification and will roll out the program to medical institutions.
The Kyoto Prefecture Medical Association is responsible for interpreting images from resident health screenings in Kyoto Prefecture. Preferred Networks is headquartered in Chiyoda-ku, Tokyo, and its President and Representative Director is Okanohara Daisuke (岡野原大輔). It has a research and development team focused on medical imaging.
Medical device certification
A registered certification body under Japan’s Pharmaceuticals and Medical Devices Act (institution name not disclosed)
PSP株式会社: Minato-ku, Tokyo; Preferred Networks: Chiyoda-ku, Tokyo
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Guidelines for Lung Cancer Screening Based on Effectiveness Evaluation (FY2006 Ministry of Health, Labour and Welfare Cancer Research Grant research group); Kaggle RSNA Pneumonia Detection Challenge
| Item | Details |
|---|---|
| Names of Products / Services Covered | AI-based chest X-ray image interpretation support program |
| Counterparty | Kyoto Prefecture Medical Association, Preferred Networks |
| Counterparty overview | The Kyoto Prefecture Medical Association is responsible for interpreting images from resident health screenings in Kyoto Prefecture. Preferred Networks is headquartered in Chiyoda-ku, Tokyo, and its President and Representative Director is Okanohara Daisuke (岡野原大輔). It has a research and development team focused on medical imaging. |
| Relationship with the Company | PSP株式会社 is a consolidated subsidiary of TECHMATRIX CORPORATION, with a 50.02% ownership stake. PSP, the Kyoto Prefecture Medical Association and Preferred Networks jointly developed this image interpretation support program. PSP obtained medical device certification and will roll out the program to medical institutions. |
| Launch date | FY2026 (scheduled; lung cancer screening conducted in Kyoto Prefecture) |
| Applicable area | Lung cancer screening in Kyoto Prefecture; chest X-ray image interpretation support |
| Award/certification name | Medical device certification |
| Awarding / certifying body | A registered certification body under Japan’s Pharmaceuticals and Medical Devices Act (institution name not disclosed) |
| Location | PSP株式会社: Minato-ku, Tokyo; Preferred Networks: Chiyoda-ku, Tokyo |
| Usage history | Pilot use in Uji City lung cancer screening in FY2025. Full-scale deployment in lung cancer screening in Kyoto Prefecture is scheduled for FY2026. |
| Source | Guidelines for Lung Cancer Screening Based on Effectiveness Evaluation (FY2006 Ministry of Health, Labour and Welfare Cancer Research Grant research group); Kaggle RSNA Pneumonia Detection Challenge |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To address challenges in securing image-reading physicians for lung cancer screening, the workload involved in image interpretation and excessive positive findings generated by existing AI, thereby reducing physicians’ workload, maintaining the image interpretation system, improving interpretation accuracy and contributing to better health among residents of Kyoto Prefecture.